Skip to main content

Topic

Patents

809 published works

  1. Foley & Lardner LLP

    Can Patent Filings Help Physical AI Companies Raise Capital?

    By Danielle Davenport

    September 2026 For autonomous systems and physical AI companies, patent cadence can be part of the fundraising story when it maps to defensible shipped technology. This article examines the latest…

  2. Spicy IP

    SpicyIP Weekly Review (14 September-20 September)

    By SpicyIP

    In this edition of the SpicyIP Weekly Review, we have comments submitted by a few of our team members on the IPO’s Draft Guidelines for Examination of Patent Applications in…

  3. Spicy IP

    Specific Comments on the IPO’s Draft Pharmaceutical Guidelines (2026)

    By Ambika Aggarwal

    There is no easier way to put it – the IPO’s Draft Guidelines for Examination of Patent Applications in the Field of Pharmaceuticals, 2026 (“2026 Draft Guidelines”) released 15 days…

  4. Patent Law Weblog

    Ex parte Chowdhury (PTAB 2026)

    By Zuhn21b31b8b84f

    By Kevin E. Noonan –On August 25th, the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office designated as Informative its decision in Ex parte Chowdhury,…

  5. Gibson Dunn

    Deal Trends — In Focus: Life Sciences

    By Gibson Dunn & Crutcher

    Deal Trends In Focus: Life Sciences Our partners share insights on the trends shaping dealmaking in the Life Sciences sector—and what to watch in the months ahead. .wp-block-media-text .wp-block-media-text__content{padding-left:32px;padding-right:0} .wp-block-media-text.has-media-on-the-right…

  6. Biosimilars Law Bulletin

    The Evolving Law of Enablement: Federal Circuit Decisions in Wyeth and Teva Form a “Yin and Yang” Framework

    By Aydin H. Harston, Anh-Thu Lam

    Two Federal Circuit decisions, three months apart, analyzed enablement of similarly broad method-of-treatment claims, but reached opposite outcomes. In April, the court reversed a JMOL of invalidity and reinstated a…

  7. RF EMerge

    The Evolving Law of Enablement: Federal Circuit Decisions in Wyeth and Teva Form a “Yin and Yang” Framework

    By Aydin H. Harston, Anh-Thu Lam

    Two Federal Circuit decisions, three months apart, analyzed enablement of similarly broad method-of-treatment claims, but reached opposite outcomes. In April, the court reversed a JMOL of invalidity and reinstated a…

  8. 3 Geeks and a Law Blog

    Patlytics and the Patent AI Race: Paul Lee on USPTO Workflows, Human Judgment, and the AI Dividend

    By Greg Lambert, Marlene Gebauer

    Paul Lee, co-founder and CEO of Patlytics, joins Greg Lambert to explain how an AI platform built specifically for intellectual property work is changing the patent lifecycle. Patlytics supports workflows…

  9. Spicy IP

    Section 14 is Not Section 25: Delhi High Court Revives Sugammadex Patent Bid

    By SpicyIP

    The Delhi High Court’s order in Fresenius Kabi v. Controller may ultimately turn on a Section 14 violation, but the concerns it flags go well beyond procedure, extending to hindsight,…

  10. Spicy IP

    General Comment on the IPO’s Draft Pharmaceutical Guidelines (2026)

    By Ambika Aggarwal

    A few days ago, we had informed our readers that they could participate in the open call for comments and suggestions on the Draft Guidelines for Examination of Patent Applications…